Catalysts
PRODUCTS
-
The LVA-6183PN+ is a wideband, ultra-low phase noise MMIC amplifier perfect for use with low noise signal sources and in sensitive transceiver chains.
-
The MM1-2567LS is a passive GaAs double-balanced MMIC mixer suitable for both up and down-conversion applications featuring excellent conversion loss, isolation, and a small form factor.
-
PHCbi brand's 18.6 cu.ft (528L) ultra-low temperature freezer offers the flexibility of operating on both 115V or 220V with the switch of a power cord. This model provides enhanced security features and operates at only 4.99kWh per day. SMART features include three lock methods: facial recognition, keypad, or optional proximity card. ENERGY STAR® Certified.
-
World's first real-time drinking water quality monitoring sensor for smart water meter. Online membrane integrity monitoring sensor for every vessel.
-
PHCbi brand’s 14.3 cu.ft. (406 L) microbiological heated and cooled incubator is designed to deliver precise, reproducible environments across a wide temperature range from -10°C to +60°C. Ideal for applications such as microbiology, food and cosmetic stability testing, plant cell culturing, and environmental studies, it supports programmable temperature and lighting protocols. The microprocessor PID controller helps ensures uniformity and stability, while the intuitive LCD interface allows for 12-step, 10-program memory with built-in alarms and backup. A forced air circulation system and energy-saving operation enhance performance and usability.
WHITE PAPERS AND CASE STUDIES
-
Working Smarter: Empowering Water Operators With Integrated Data
As water utilities face the challenges of sustainability, efficiency, and service quality, digital technology has become a necessity. The right tech can help deliver reliable service, optimize systems, and meet sustainability goals, but integrating the data streams these solutions generate can offer even greater gains – allowing utilities to move faster and achieve more powerful outcomes.
-
Leveraging High-Pressure Sterile Filtration For Highly Viscous Solutions
This research demonstrates the potential of high-pressure sterile filtration to enhance efficiency, reduce waste, and accelerate the development of innovative therapies.
-
Global Start-Up For Multinational Geographic Atrophy Trial
This partnership allowed a leading biopharmaceutical company to navigate the complexities of a Phase IIb study investigating a novel pegylated RNA adapter for geographic atrophy secondary to dry AMD.
-
Executing Concurrent Decentralized RCTs And RWE At Scale
See how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.
-
Duchenne Muscular Dystrophy Trial In China
A global sponsor conducting a Duchenne Muscular Dystrophy trial in China required reliable patient travel solutions to support children and families.
-
Improving Patient Health And Safety
Engage an experienced CMC program management consultant to collaboratively develop and maintain a robust product development plan (PDP) with your team lead, cross-functional members, and vendors.
-
The City Of Fayetteville's Flood Resiliency In The Face Of Climate Change: Mapping 15 Watersheds
The city of Fayetteville, North Carolina has always had flooding issues, but it’s been getting worse as weather patterns have been changing. They were hit four years in a row by storms Matthew (2016), Irma (2017), Florence (2018), and Dorian (2019).
-
Mobile Gowning Cleanroom, Built To Meet ISO 7 Requirements
Uncover how Germfree designed and installed a mobile cGMP cleanroom on a 53′ tractor-trailer chassis to provide a flexible and efficient cleanroom solution tailored to the company’s needs.
-
A Community-Focused Approach To Metabolic Disease Trials
Learn how innovative strategies like free health exams, community engagement, and a comprehensive patient database helped this project achieve rapid enrollment with a high level of patient diversity.
-
How eSource Reduced Benchmark's Protocol Deviations By Almost 40%
Explore how a leading vaccine site network selected CRIO to help address the challenges with it's use of paper charts in collecting source data.
-
Using Virtual Study Coordinators For EDC Entry And Query Resolution To Speed Up Data Access And Cleaning
The piece showcases how the effective use of CRIO can significantly enhance site performance, supporting recruitment and diversity objectives for sponsors.
-
How Optina Diagnostics Used EDC In Earlier Disease Detection
Understand how Optina Diagnostics streamlined operations and achieved significant milestones by leveraging Castor's tools in its effort to revolutionize the diagnostic process for Alzheimer’s.
NEWS
-
Quantum Biopharma Announces Signing Of An Agreement With A Global Pharmaceutical Contract Research Organization To Prepare An IND (Investigational New Drug) Application Package For Lucid-21-302 (Lucid-MS), A First-In-Class Treatment For Multiple Sclerosis5/20/2025
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that it has signed an agreement with a global pharmaceutical contract research organization to prepare an IND (Investigational New Drug) application package for Lucid-21-302 (Lucid-MS) with the US FDA.
-
Anritsu Unveils New Software-Based Solution For 5G IoT Chipset And Device Development Tests2/28/2025
Anritsu Corporation is proud to introduce the Virtual Signalling Tester NR Software MX844030PC, a software-based test simulator for developing 5G IoT chipsets and devices. The solution supports 5G IoT test by using a new simulator that operates in a virtual environment on a PC using advanced architecture, as well as a Software Defined Radio (SDR) that implements most conventional radio functions in software.
-
Silo Pharma Expands Intellectual Property Portfolio With Patent Application For Exclusively Licensed Alzheimer's Drug4/28/2025
Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the filing of a patent application with the U.S. Patent and Trademark Office (USPTO) focused on the neurology drug SPC-14, an intranasal compound for the treatment of Alzheimer’s disease (AD) exclusively licensed to Silo Pharma from Columbia University.
-
New Land Grant Research Detects Dicamba Damage From The Sky7/9/2025
Drones can now detect subtle soybean canopy damage from dicamba at one ten-thousandth of the herbicide’s label rate — simulating vapor drift — eight days after application.
-
Shell Expands Gulf Of America Leadership Position With Dover Development4/8/2025
Shell Offshore Inc. (Shell), a subsidiary of Shell plc, today announced the start of production at Dover, the second subsea tieback connecting new wells to the existing infrastructure of the Shell-operated Appomattox production hub in the Gulf of America.
ABOUT
Catalysts
Catalysts work by changing the structure of a molecule or by bonding to reactant molecules causing them to combine, react, and release a product or energy. For example, a catalyst is required in order for oxygen and hydrogen to bond, combine and produce water.
Catalysts increase the rate of chemical reactions. Unlike a reagent that gets consumed as apart of the chemical reaction, catalysts do not get consumed in the reaction. They can actually participate in multiple chemical transformations.Catalysts can be organic, synthetic or metal.
All processes need energy to take place. Processes require a very high level of energy in order to spark or start if a catalyst isn’t present. When a catalyst is present the amount of energy required to spark the reaction is lowered and that makes the reaction happen faster and more efficiently.
Catalytic effects vary depending on other substances present that are a part of the chemical reactions. There are certain substances that can inhibit the effectiveness of a catalyst like poisons, and other substances that promote or increase the effect of the catalyst. Inhibitors or negative catalysts are very important in medicine to treat mental illnesses, high blood pressure, cancer and many other diseases.
Catalysts are often used to help crack, or split, larger organic molecules like hydrocarbons into simpler molecules. It does this by breaking carbon-carbon bonds. The speed of the splitting process depends heavily on what specific catalyst is used and the temperature. Applications of this technology include oil and petrochemical industries.